Status:

WITHDRAWN

DHA Proof-of-Concept Study in Infants and Toddlers

Lead Sponsor:

Société des Produits Nestlé (SPN)

Conditions:

Infants

Toddlers

Eligibility:

All Genders

2-14 years

Phase:

NA

Brief Summary

This is a prospective, double blind, randomized, controlled proof-of-concept study with a parallel group design that aims to investigate the effect of a liquid oral supplement comprising a blend of gl...

Eligibility Criteria

Inclusion

  • Subjects who fulfil all of the following inclusion criteria will be included:
  • Evidence of personally signed and dated informed consent form indicating that the infant/toddler's parent(s)/ Legally Authorized representative (LAR) has been informed of all pertinent aspects of the study.
  • Infants/toddlers whose parent(s)/LAR are willing and able to comply with scheduled visits, and the requirements of the study protocol.
  • Infants/toddlers must meet the following inclusion criteria respectively to be eligible for enrollment into the study:
  • Healthy normally developing infant/toddler at the discretion of the investigator.
  • Healthy term infant (37-42 weeks of gestation) at birth.
  • At enrollment visit, post-natal age 2-3 months (60-90 days) for infants or 13-14 months for toddlers (date of birth = day 0).
  • For the infant group, infants must have been exclusively consuming and tolerating a cow's milk infant formula not containing DHA for the past month, and their parent(s)/LAR must have independently elected, before enrolment, not to breastfeed.
  • For the toddler group, toddlers must have been consuming and tolerating a cow's milk TMS not containing DHA for the past month.
  • Infants or toddlers must not have been consuming DHA-containing supplements for the past month.

Exclusion

  • Any of the following criteria would render a subject ineligible for inclusion:
  • Infants/toddlers with conditions requiring feedings other than those specified in the protocol.
  • Infants receiving complementary foods or liquids defined as 4 or more teaspoons per day or approximately 20 grams (g) per day of complementary foods or liquids at enrollment.
  • Infants/toddlers who have a medical condition or history that could increase the risk associated with study participation or interfere with the interpretation of study results, including:
  • Evidence of major congenital malformations (e.g., cleft palate, extremity malformation).
  • Suspected or documented systemic or congenital infections (e.g., human immunodeficiency virus, cytomegalovirus, syphilis).
  • Evidence of significant cardiac, respiratory, endocrinologic, hematologic, gastrointestinal (e.g., complicated gastroesophageal reflux combined with inadequate growth and/or respiratory complications, Hirschsprung's disease), or other systemic diseases.
  • History of admission to the Neonatal Intensive Care Unit, with the exception of admission for jaundice phototherapy.
  • Currently participating or having participated in another clinical trial since birth.
  • Other severe medical or laboratory abnormality (acute or chronic) which, in the judgment of the investigator, would make the infant/toddler inappropriate for entry into the study.
  • Infants/toddlers who are presently receiving or have received prior to enrollment any of the following: medication(s) or supplement(s) which are known or suspected to affect fat digestion, absorption, and/or metabolism (e.g., lactase enzymes, pancreatic enzymes); medications that may neutralize or suppress gastric acid secretion; medications that could affect any study outcomes.
  • Infants/toddlers whose parent(s)/LAR who in the Investigator's assessment cannot be expected to comply with the protocol or with study procedures.

Key Trial Info

Start Date :

July 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05266677

Start Date

July 1 2022

End Date

May 1 2023

Last Update

July 18 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.